Tag results:
pancreatic ductal adenocarcinoma
Pancreatic Cell News
Reciprocal Regulation of LOXL2 and HIF1α Drives the Warburg Effect to Support Pancreatic Cancer Aggressiveness
[Cell Death & Disease] The authors identified that lysyl oxidase-like 2 was a hypoxia-responsive gene and is essential for the Warburg effect in PDAC.
Pancreatic Cell News
Prognostic Role of Cell-Free DNA Biomarkers in Pancreatic Adenocarcinoma: A Systematic Review and Meta–Analysis
[Critical Reviews in Oncology Hematology] Cell-free DNA biomarkers indicate accelerated progression and decreased survival in PDAC.
Organoid News
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer
[Clinical Cancer Research] Prospectively generate patient derived organoids were established from a heterogeneous population of patients with pancreatic ductal adenocarcinoma (PDAC) including both basal and classical PDAC subtypes.
Immune Regulation News
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Limitations and Prospects: A Systematic Review
[Cell Communication and Signaling] Pancreatic ductal adenocarcinoma is not sensitive to monotherapy with immune checkpoint inhibitors, which might be related to the inhibitory immune microenvironment of pancreatic cancer.
Pancreatic Cell News
Glycosylation of MUC6 by α1,4-Linked N-acetylglucosamine Enhances Suppression of Pancreatic Cancer Malignancy
[Cancer Science] Investigators ectopically expressed α1,4-N-acetylglucosaminyltransferase (α4GnT), the α1,4-linked N-acetylglucosamine biosynthetic enzyme, together with MUC6 in the human pancreatic cancer cell lines MIA PaCa-2 and PANC-1, neither of which expressed α4GnT and MUC6.
Pancreatic Cell News
Modulation of Pancreatic Cancer Cell Sensitivity to FOLFIRINOX through microRNA-Mediated Regulation of DNA Damage
[Nature Communications] Scientists found that 41 and 84 microRNA inhibitors enhanced the sensitivity of Capan1 and MiaPaCa2 pancreatic ductal adenocarcinoma cells respectively.